RheaBiotech provides immunological solutions through the production of antibodies and recombinant proteins, supporting the development of research and the national biotechnology industry. The company also has know-how for the production of hybridomas.
BUSINESS MODEL: B2B and B2C
STAGE: Commercial approval
For further information, please contact us.
Back to Investors page